PMCID string | Sentences string | ner list |
|---|---|---|
PMC11596967 | The ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)) assay was performed following the modified protocol by Re et al. . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"ABTS",
"(",
"2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic",
"acid",
")",
")",
"assay",
"was",
"performed",
"following",
"the",
"modified",
"protocol",
"by",
"Re",
"et",
"al.",
"."
]
}
] |
PMC11248911 | All experiments were conducted in triplicate (n = 3). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"experiments",
"were",
"conducted",
"in",
"triplicate",
"(",
"n",
"=",
"3",
")",
"."
]
}
] |
PMC11546117 | Within the OAT subfamily, we showed expression, even if very low, of OAT1 (SLC22A6), OAT2 (SLC22A7), and OAT3 (SCL22A8), while these genes were below the detection level in non-lactating cells according to Alcorn et al. (2022) . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Within",
"the",
"OAT",
"subfamily",
",",
"we",
"showed",
"expression",
",",
"even",
"if",
"very",
"low",
",",
"of",
"OAT1",
"(",
"SLC22A6",
")",
",",
"OAT2",
"(",
"SLC22A7",
")",
",",
"and",
"OAT3",
"(",
"SCL22A8",
")",
",",
"while",
"these",
"genes",
"were",
"below",
"the",
"detection",
"level",
"in",
"non-lactating",
"cells",
"according",
"to",
"Alcorn",
"et",
"al.",
"(",
"2022",
")",
"."
]
}
] |
PMC9577200 | Then, 2 ml of LB medium was added to the mixture in 5 ml tubes, and the tubes were kept on a rotary shaker at 120 rpm and 30°C. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Then",
",",
"2",
"ml",
"of",
"LB",
"medium",
"was",
"added",
"to",
"the",
"mixture",
"in",
"5",
"ml",
"tubes",
",",
"and",
"the",
"tubes",
"were",
"kept",
"on",
"a",
"rotary",
"shaker",
"at",
"120",
"rpm",
"and",
"30",
"°",
"C",
"."
]
}
] |
PMC11592837 | DOX was reported to generate reactive oxygen species, lipid peroxidation, membrane damage and mitochondrial degeneration . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"DOX",
"was",
"reported",
"to",
"generate",
"reactive",
"oxygen",
"species",
",",
"lipid",
"peroxidation",
",",
"membrane",
"damage",
"and",
"mitochondrial",
"degeneration",
"."
]
}
] |
PMC3203927 | An interaction with a material which yields cells that emulate in vivo conditions would be most desirable. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"An",
"interaction",
"with",
"a",
"material",
"which",
"yields",
"cells",
"that",
"emulate",
"in",
"vivo",
"conditions",
"would",
"be",
"most",
"desirable",
"."
]
}
] |
PMC5363531 | Genomic DNA (gDNA) was extracted using Wizard Genomic DNA Purification Kit (Promega) following the manufacturer's instructions. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Genomic",
"DNA",
"(",
"gDNA",
")",
"was",
"extracted",
"using",
"Wizard",
"Genomic",
"DNA",
"Purification",
"Kit",
"(",
"Promega",
")",
"following",
"the",
"manufacturer",
"'s",
"instructions",
"."
]
}
] |
PMC8922418 | However, the difficulty and complexity of pegRNA design for PE are much higher than those of sgRNA for BE. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"the",
"difficulty",
"and",
"complexity",
"of",
"pegRNA",
"design",
"for",
"PE",
"are",
"much",
"higher",
"than",
"those",
"of",
"sgRNA",
"for",
"BE",
"."
]
}
] |
PMC9429973 | These data indicate that MRK-560 synergizes with dexamethasone via downregulation of HES-1 (downstream of NOTCH1), resulting in enhanced glucocorticoid signaling with higher BIM expression levels and apoptosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"data",
"indicate",
"that",
"MRK-560",
"synergizes",
"with",
"dexamethasone",
"via",
"downregulation",
"of",
"HES-1",
"(",
"downstream",
"of",
"NOTCH1",
")",
",",
"resulting",
"in",
"enhanced",
"glucocorticoid",
"signaling",
"with",
"higher",
"BIM",
"expression",
"levels",
"and",
"apoptosis",
"."
]
}
] |
PMC6901583 | This work explored whether BRD4 was associated with this pathway and reported that increased levels of BRD4 led to the in vitro and in vivo formation of HUVEC tubes. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"work",
"explored",
"whether",
"BRD4",
"was",
"associated",
"with",
"this",
"pathway",
"and",
"reported",
"that",
"increased",
"levels",
"of",
"BRD4",
"led",
"to",
"the",
"in",
"vitro",
"and",
"in",
"vivo",
"formation",
"of",
"HUVEC",
"tubes",
"."
]
}
] |
PMC7171147 | There are two possible explanations for co-activation of FAO and fatty acid synthesis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"There",
"are",
"two",
"possible",
"explanations",
"for",
"co-activation",
"of",
"FAO",
"and",
"fatty",
"acid",
"synthesis",
"."
]
}
] |
PMC9096373 | Specific-pathogen-free (SPF) feeding was carried out at the medical laboratory animal center. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Specific-pathogen-free",
"(",
"SPF",
")",
"feeding",
"was",
"carried",
"out",
"at",
"the",
"medical",
"laboratory",
"animal",
"center",
"."
]
}
] |
PMC11347429 | Pathway analysis for DEGs between infected patients and healthy controls agreed with other studies of influenza-infected patients regarding upregulation of common virus-host defense pathways ( Figure 2 ; Data file 6 ) (17–33) and other respiratory virus infections (33). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Pathway",
"analysis",
"for",
"DEGs",
"between",
"infected",
"patients",
"and",
"healthy",
"controls",
"agreed",
"with",
"other",
"studies",
"of",
"influenza-infected",
"patients",
"regarding",
"upregulation",
"of",
"common",
"virus-host",
"defense",
"pathways",
"(",
"Figure",
"2",
";",
"Data",
"file",
"6",
")",
"(",
"17–33",
")",
"and",
"other",
"respiratory",
"virus",
"infections",
"(",
"33",
")",
"."
]
}
] |
PMC9822769 | Very recently, the role of volume-regulated anion channels VRACs, best known for their role in cell-volume homeostasis, has been postulated in the transport of cisplatin and its Pt(II) congeners . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Very",
"recently",
",",
"the",
"role",
"of",
"volume-regulated",
"anion",
"channels",
"VRACs",
",",
"best",
"known",
"for",
"their",
"role",
"in",
"cell-volume",
"homeostasis",
",",
"has",
"been",
"postulated",
"in",
"the",
"transport",
"of",
"cisplatin",
"and",
"its",
"Pt(II",
")",
"congeners",
"."
]
}
] |
PMC11228511 | To test this hypothesis, we used doxycycline (Dox)-inducible vectors to create SMCs that express prelamin A (which is processed to mature lamin A) as well as SMCs that express progerin. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"test",
"this",
"hypothesis",
",",
"we",
"used",
"doxycycline",
"(Dox)-inducible",
"vectors",
"to",
"create",
"SMCs",
"that",
"express",
"prelamin",
"A",
"(",
"which",
"is",
"processed",
"to",
"mature",
"lamin",
"A",
")",
"as",
"well",
"as",
"SMCs",
"that",
"express",
"progerin",
"."
]
}
] |
PMC11265931 | Subsequently, 100 μL of prepared Streptavidin solution was added to each labeled well and incubated for 45 min at room temperature with gentle shaking. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Subsequently",
",",
"100",
"μL",
"of",
"prepared",
"Streptavidin",
"solution",
"was",
"added",
"to",
"each",
"labeled",
"well",
"and",
"incubated",
"for",
"45",
"min",
"at",
"room",
"temperature",
"with",
"gentle",
"shaking",
"."
]
}
] |
PMC7053076 | Various members of the NF-κB family are constitutively activated in many cancers via one of the two pathways: the canonical pathway involving RelA, NF-κB1 p50 and c-Rel and the non-canonical pathway engaging RelB and NF-κB2 p52. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Various",
"members",
"of",
"the",
"NF-κB",
"family",
"are",
"constitutively",
"activated",
"in",
"many",
"cancers",
"via",
"one",
"of",
"the",
"two",
"pathways",
":",
"the",
"canonical",
"pathway",
"involving",
"RelA",
",",
"NF-κB1",
"p50",
"and",
"c-Rel",
"and",
"the",
"non-canonical",
"pathway",
"engaging",
"RelB",
"and",
"NF-κB2",
"p52",
"."
]
}
] |
PMC11792766 | Data are shown as mean + standard error of the mean (SEM) (n = 9). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Data",
"are",
"shown",
"as",
"mean",
"+",
"standard",
"error",
"of",
"the",
"mean",
"(",
"SEM",
")",
"(",
"n",
"=",
"9",
")",
"."
]
}
] |
PMC6182045 | Affinity purified polyclonal goat antibodies, raised against an equimolar mixture of purified gp120s from clade B (MN), clade C (CN97001), and clade E (TH023) gp120s, was used as a positive control for the FIA binding assays. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Affinity",
"purified",
"polyclonal",
"goat",
"antibodies",
",",
"raised",
"against",
"an",
"equimolar",
"mixture",
"of",
"purified",
"gp120s",
"from",
"clade",
"B",
"(",
"MN",
")",
",",
"clade",
"C",
"(",
"CN97001",
")",
",",
"and",
"clade",
"E",
"(",
"TH023",
")",
"gp120s",
",",
"was",
"used",
"as",
"a",
"positive",
"control",
"for",
"the",
"FIA",
"binding",
"assays",
"."
]
}
] |
PMC11388384 | SCUBE1 expanded SHH signaling gradients in a dose-dependent manner. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"SCUBE1",
"expanded",
"SHH",
"signaling",
"gradients",
"in",
"a",
"dose-dependent",
"manner",
"."
]
}
] |
PMC11335267 | Receptors for leptin (LepR), ghrelin (GHSR), adenosine (AdRA1), melanocortin (MC3R and MC4R), glucagon-like peptide 1 (GLP1R) and erythropoietin (EpoR) were tested (n = 8 per genotype except for EpoR, 5 wild type and 6 Alx3-deficient mice). ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Receptors",
"for",
"leptin",
"(",
"LepR",
")",
",",
"ghrelin",
"(",
"GHSR",
")",
",",
"adenosine",
"(",
"AdRA1",
")",
",",
"melanocortin",
"(",
"MC3R",
"and",
"MC4R",
")",
",",
"glucagon-like",
"peptide",
"1",
"(",
"GLP1R",
")",
"and",
"erythropoietin",
"(",
"EpoR",
")",
"were",
"tested",
"(",
"n",
"=",
"8",
"per",
"genotype",
"except",
"for",
"EpoR",
",",
"5",
"wild",
"type",
"and",
"6",
"Alx3-deficient",
"mice",
")",
".",
"("
]
}
] |
PMC9429973 | No changes in IgG levels were observed in patients treated with placebo during that time. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"No",
"changes",
"in",
"IgG",
"levels",
"were",
"observed",
"in",
"patients",
"treated",
"with",
"placebo",
"during",
"that",
"time",
"."
]
}
] |
PMC11434983 | The cytotoxicity of the new compound is also within the range of the cytotoxic activity reported for the first generation EGFR TKIs currently used in clinical practice since, in the literature, the IC50 values for gefitinib, erlotinib, lapatinib, using the A431 cell line, range from 1.33 to 4.80 μΜ . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"cytotoxicity",
"of",
"the",
"new",
"compound",
"is",
"also",
"within",
"the",
"range",
"of",
"the",
"cytotoxic",
"activity",
"reported",
"for",
"the",
"first",
"generation",
"EGFR",
"TKIs",
"currently",
"used",
"in",
"clinical",
"practice",
"since",
",",
"in",
"the",
"literature",
",",
"the",
"IC50",
"values",
"for",
"gefitinib",
",",
"erlotinib",
",",
"lapatinib",
",",
"using",
"the",
"A431",
"cell",
"line",
",",
"range",
"from",
"1.33",
"to",
"4.80",
"μΜ",
"."
]
}
] |
PMC7189327 | Additionally, CYFIP2, HOXB5, PTPN3, MARCKSL, CDC20, and PTCH1 had superior diagnostic values for BCC prediction. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Additionally",
",",
"CYFIP2",
",",
"HOXB5",
",",
"PTPN3",
",",
"MARCKSL",
",",
"CDC20",
",",
"and",
"PTCH1",
"had",
"superior",
"diagnostic",
"values",
"for",
"BCC",
"prediction",
"."
]
}
] |
PMC11763764 | After washing with 1× wash buffer A twice, the ligation mix was incubated for 30 min at 37 °C. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"washing",
"with",
"1",
"×",
"wash",
"buffer",
"A",
"twice",
",",
"the",
"ligation",
"mix",
"was",
"incubated",
"for",
"30",
"min",
"at",
"37",
"°",
"C",
"."
]
}
] |
PMC10006224 | We next defined “gained” loops as those called only in NIPBL KD replicates and “lost” loops as those called only in wild type replicates. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"next",
"defined",
"“",
"gained",
"”",
"loops",
"as",
"those",
"called",
"only",
"in",
"NIPBL",
"KD",
"replicates",
"and",
"“",
"lost",
"”",
"loops",
"as",
"those",
"called",
"only",
"in",
"wild",
"type",
"replicates",
"."
]
}
] |
PMC11047729 | Fatty acids C18–C22 directly affect telomerase activity. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Fatty",
"acids",
"C18–C22",
"directly",
"affect",
"telomerase",
"activity",
"."
]
}
] |
PMC11640247 | Biochemical and cell biological analyses indicated that RAC3-R66W functions as an activated variant in vitro (Figure 1 and Figure 2). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Biochemical",
"and",
"cell",
"biological",
"analyses",
"indicated",
"that",
"RAC3-R66W",
"functions",
"as",
"an",
"activated",
"variant",
"in",
"vitro",
"(",
"Figure",
"1",
"and",
"Figure",
"2",
")",
"."
]
}
] |
PMC9872547 | Free curcumin with a higher concentration (50 μM) could induce apoptosis in 25.9% of cells (Figure 2). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Free",
"curcumin",
"with",
"a",
"higher",
"concentration",
"(",
"50",
"μM",
")",
"could",
"induce",
"apoptosis",
"in",
"25.9",
"%",
"of",
"cells",
"(",
"Figure",
"2",
")",
"."
]
}
] |
PMC11711347 | Cisplatin functions as a cytostatic agent by inhibiting DNA synthesis, leading to cancer cell death . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cisplatin",
"functions",
"as",
"a",
"cytostatic",
"agent",
"by",
"inhibiting",
"DNA",
"synthesis",
",",
"leading",
"to",
"cancer",
"cell",
"death",
"."
]
}
] |
PMC9429973 | In 2014, ibrutinib was approved by the European Medicines Agency and made available to CLL pts in Germany. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"2014",
",",
"ibrutinib",
"was",
"approved",
"by",
"the",
"European",
"Medicines",
"Agency",
"and",
"made",
"available",
"to",
"CLL",
"pts",
"in",
"Germany",
"."
]
}
] |
PMC8633974 | After 72 hours following electroporation, ACH2 cells were stimulated with TNF-α (15 ng/mL). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"72",
"hours",
"following",
"electroporation",
",",
"ACH2",
"cells",
"were",
"stimulated",
"with",
"TNF-α",
"(",
"15",
"ng/mL",
")",
"."
]
}
] |
PMC11752740 | For this study, we used fresh Pistacia vera var. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"this",
"study",
",",
"we",
"used",
"fresh",
"Pistacia",
"vera",
"var",
"."
]
}
] |
PMC11806613 | Quantification of protein expressions are shown on top. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Quantification",
"of",
"protein",
"expressions",
"are",
"shown",
"on",
"top",
"."
]
}
] |
PMC6892818 | Lysate from effector (3T3CD40L) cells alone (20 µg protein/lane) served as negative control (NC) and confirmed the human-protein specificity of the anti-TRAF1 (a), anti-TRAF2 (b) and anti-TRAF3 (c) antibodies. | [
{
"tags": [
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Lysate",
"from",
"effector",
"(",
"3T3CD40L",
")",
"cells",
"alone",
"(",
"20",
"µg",
"protein/lane",
")",
"served",
"as",
"negative",
"control",
"(",
"NC",
")",
"and",
"confirmed",
"the",
"human-protein",
"specificity",
"of",
"the",
"anti-TRAF1",
"(",
"a",
")",
",",
"anti-TRAF2",
"(",
"b",
")",
"and",
"anti-TRAF3",
"(",
"c",
")",
"antibodies",
"."
]
}
] |
PMC11748335 | Hence, we downloaded TE regions from the UCSC database and obtained DMV regions from a previous study . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Hence",
",",
"we",
"downloaded",
"TE",
"regions",
"from",
"the",
"UCSC",
"database",
"and",
"obtained",
"DMV",
"regions",
"from",
"a",
"previous",
"study",
"."
]
}
] |
PMC11449273 | Conversely, plakoglobin has a p53-dependent effect (whether wild-type or mutant) on S100A4 expression as evidenced by the decreased trend of S100A4 expression when plakoglobin was co-expressed in either H1299- p53- (WT, 175, or 273) cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Conversely",
",",
"plakoglobin",
"has",
"a",
"p53-dependent",
"effect",
"(",
"whether",
"wild-type",
"or",
"mutant",
")",
"on",
"S100A4",
"expression",
"as",
"evidenced",
"by",
"the",
"decreased",
"trend",
"of",
"S100A4",
"expression",
"when",
"plakoglobin",
"was",
"co-expressed",
"in",
"either",
"H1299-",
"p53-",
"(",
"WT",
",",
"175",
",",
"or",
"273",
")",
"cells",
"."
]
}
] |
PMC11407042 | Extend the incubation time if digestion is incomplete, but not exceed 5 min. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Extend",
"the",
"incubation",
"time",
"if",
"digestion",
"is",
"incomplete",
",",
"but",
"not",
"exceed",
"5",
"min",
"."
]
}
] |
PMC11279598 | Cell number counts were performed, and cell proliferation was quantitated by colorimetric assays using the CellTiter 96 Aqueous (Promega, San Luis Obispo, CA, USA) assay as per the manufacturer’s instructions . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cell",
"number",
"counts",
"were",
"performed",
",",
"and",
"cell",
"proliferation",
"was",
"quantitated",
"by",
"colorimetric",
"assays",
"using",
"the",
"CellTiter",
"96",
"Aqueous",
"(",
"Promega",
",",
"San",
"Luis",
"Obispo",
",",
"CA",
",",
"USA",
")",
"assay",
"as",
"per",
"the",
"manufacturer",
"’s",
"instructions",
"."
]
}
] |
PMC11759543 | In control and vorinostat-only groups, the mice's body weight did not decrease, and the tumor did not reduce either. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"control",
"and",
"vorinostat-only",
"groups",
",",
"the",
"mice",
"'s",
"body",
"weight",
"did",
"not",
"decrease",
",",
"and",
"the",
"tumor",
"did",
"not",
"reduce",
"either",
"."
]
}
] |
PMC11802855 | 1CXCL7 plays a crucial role in the proliferation of multiple myeloma and the activation of osteoclast signaling pathways. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"1CXCL7",
"plays",
"a",
"crucial",
"role",
"in",
"the",
"proliferation",
"of",
"multiple",
"myeloma",
"and",
"the",
"activation",
"of",
"osteoclast",
"signaling",
"pathways",
"."
]
}
] |
PMC11271278 | To make cDNA for RT-qPCR, 1μg of RNA was used with the NEB LunaScript SuperMix kit. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"make",
"cDNA",
"for",
"RT-qPCR",
",",
"1μg",
"of",
"RNA",
"was",
"used",
"with",
"the",
"NEB",
"LunaScript",
"SuperMix",
"kit",
"."
]
}
] |
PMC9429973 | ICU admission following HSCT is associated with poor prognosis, but should not be considered futile. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"ICU",
"admission",
"following",
"HSCT",
"is",
"associated",
"with",
"poor",
"prognosis",
",",
"but",
"should",
"not",
"be",
"considered",
"futile",
"."
]
}
] |
PMC10729469 | E Quantification of F-FDG PET brain glucose uptake on the day of sacrifice (n = 5—6). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"E",
"Quantification",
"of",
"F-FDG",
"PET",
"brain",
"glucose",
"uptake",
"on",
"the",
"day",
"of",
"sacrifice",
"(",
"n",
"=",
"5—6",
")",
"."
]
}
] |
PMC11317131 | We first optimized PE for inserting the PhiC31 att sites to act as a landing pad for insertion. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"first",
"optimized",
"PE",
"for",
"inserting",
"the",
"PhiC31",
"att",
"sites",
"to",
"act",
"as",
"a",
"landing",
"pad",
"for",
"insertion",
"."
]
}
] |
PMC11755467 | The recent intriguing discovery that Enoxacin modulated miRNA processing prompted us to investigate a potential anti-HIV-1 replicative effect in vitro in the context of miRNAs playing substantial roles in the HIV-1 life cycle . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"recent",
"intriguing",
"discovery",
"that",
"Enoxacin",
"modulated",
"miRNA",
"processing",
"prompted",
"us",
"to",
"investigate",
"a",
"potential",
"anti-HIV-1",
"replicative",
"effect",
"in",
"vitro",
"in",
"the",
"context",
"of",
"miRNAs",
"playing",
"substantial",
"roles",
"in",
"the",
"HIV-1",
"life",
"cycle",
"."
]
}
] |
PMC11310713 | After 12 weeks, the OVX rats that received pharmaceutical HRT changed their body weight to −3.45% for low E2, −4.49% for low E2 + P4, −4.94% for high E2, and −4.59% for high E2 + P4 treatment, while the body weight of the GTB-injected rats was, on average, 18.4% that of ovary-intact rats. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"12",
"weeks",
",",
"the",
"OVX",
"rats",
"that",
"received",
"pharmaceutical",
"HRT",
"changed",
"their",
"body",
"weight",
"to",
"−3.45",
"%",
"for",
"low",
"E2",
",",
"−4.49",
"%",
"for",
"low",
"E2",
"+",
"P4",
",",
"−4.94",
"%",
"for",
"high",
"E2",
",",
"and",
"−4.59",
"%",
"for",
"high",
"E2",
"+",
"P4",
"treatment",
",",
"while",
"the",
"body",
"weight",
"of",
"the",
"GTB-injected",
"rats",
"was",
",",
"on",
"average",
",",
"18.4",
"%",
"that",
"of",
"ovary-intact",
"rats",
"."
]
}
] |
PMC11786156 | Cluster of Differentiation 54 (CD54), also known as intracellular adhesion molecule-1 (ICAM-1), is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cluster",
"of",
"Differentiation",
"54",
"(",
"CD54",
")",
",",
"also",
"known",
"as",
"intracellular",
"adhesion",
"molecule-1",
"(",
"ICAM-1",
")",
",",
"is",
"a",
"transmembrane",
"glycoprotein",
"belonging",
"to",
"the",
"immunoglobulin",
"superfamily",
"."
]
}
] |
PMC9919300 | Data are expressed as the fold change using 2 method referred to “control plus steatogenic medium (P/O)” as the control group. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Data",
"are",
"expressed",
"as",
"the",
"fold",
"change",
"using",
"2",
"method",
"referred",
"to",
"“",
"control",
"plus",
"steatogenic",
"medium",
"(",
"P/O",
")",
"”",
"as",
"the",
"control",
"group",
"."
]
}
] |
PMC11225860 | SCID mice were injected with 1 × 106 VAL cells in sterile saline subcutaneously in the left flank. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"SCID",
"mice",
"were",
"injected",
"with",
"1",
"×",
"106",
"VAL",
"cells",
"in",
"sterile",
"saline",
"subcutaneously",
"in",
"the",
"left",
"flank",
"."
]
}
] |
PMC11767817 | The cumene hydroperoxide was used at a concentration of 4.5 mM. The cells were washed twice with DPBS and resuspended in 200 µL of DPBS. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"cumene",
"hydroperoxide",
"was",
"used",
"at",
"a",
"concentration",
"of",
"4.5",
"mM.",
"The",
"cells",
"were",
"washed",
"twice",
"with",
"DPBS",
"and",
"resuspended",
"in",
"200",
"µL",
"of",
"DPBS",
"."
]
}
] |
PMC11590005 | Students enrolled in private dental schools had high-er B-MRS sum-score than those from public dental schools (p = 0.001). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Students",
"enrolled",
"in",
"private",
"dental",
"schools",
"had",
"high-er",
"B-MRS",
"sum-score",
"than",
"those",
"from",
"public",
"dental",
"schools",
"(",
"p",
"=",
"0.001",
")",
"."
]
}
] |
PMC10047551 | EGFR TKI resistance mechanisms are pleiotropic and involve secondary EGFR mutations, amplification of the mesenchymal–epithelial transition factor proto-oncogene (c-MET), and epithelial–mesenchymal transition (EMT) . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"EGFR",
"TKI",
"resistance",
"mechanisms",
"are",
"pleiotropic",
"and",
"involve",
"secondary",
"EGFR",
"mutations",
",",
"amplification",
"of",
"the",
"mesenchymal",
"–",
"epithelial",
"transition",
"factor",
"proto-oncogene",
"(",
"c-MET",
")",
",",
"and",
"epithelial",
"–",
"mesenchymal",
"transition",
"(",
"EMT",
")",
"."
]
}
] |
PMC11306331 | We chose MBP as a lead candidate (size: 41 Da; pI = 5.2; see Fig. S1A for surface electrostatics and aromatic residues), a protein commonly used to increase the solubility of proteins purified from bacterial expression systems. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"chose",
"MBP",
"as",
"a",
"lead",
"candidate",
"(",
"size",
":",
"41",
"Da",
";",
"pI",
"=",
"5.2",
";",
"see",
"Fig.",
"S1A",
"for",
"surface",
"electrostatics",
"and",
"aromatic",
"residues",
")",
",",
"a",
"protein",
"commonly",
"used",
"to",
"increase",
"the",
"solubility",
"of",
"proteins",
"purified",
"from",
"bacterial",
"expression",
"systems",
"."
]
}
] |
PMC11656657 | In contrast, in mice treated with CAR.GD2 T-cells, we observed a significant increase of circulating T-cells from 13.44% ± 11.60% at day + 21 to 25.48% ± 10.65% at day + 47 (p = 0.04) (Fig. 4E), with human T-cells as well as CAR + T-cells being detectable up to the last time-point of the experiment (day + 75; Supplemental Fig. 9C), suggesting a consistent CAR representation in the circulating T-cells over time (Supplemental Fig. 9C). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"contrast",
",",
"in",
"mice",
"treated",
"with",
"CAR.GD2",
"T-cells",
",",
"we",
"observed",
"a",
"significant",
"increase",
"of",
"circulating",
"T-cells",
"from",
"13.44",
"%",
"±",
"11.60",
"%",
"at",
"day",
"+",
"21",
"to",
"25.48",
"%",
"±",
"10.65",
"%",
"at",
"day",
"+",
"47",
"(",
"p",
"=",
"0.04",
")",
"(",
"Fig.",
"4E",
")",
",",
"with",
"human",
"T-cells",
"as",
"well",
"as",
"CAR",
"+",
"T-cells",
"being",
"detectable",
"up",
"to",
"the",
"last",
"time-point",
"of",
"the",
"experiment",
"(",
"day",
"+",
"75",
";",
"Supplemental",
"Fig.",
"9C",
")",
",",
"suggesting",
"a",
"consistent",
"CAR",
"representation",
"in",
"the",
"circulating",
"T-cells",
"over",
"time",
"(",
"Supplemental",
"Fig.",
"9C",
")",
"."
]
}
] |
PMC11063646 | Utilizing Design-Expert (Version 11, State-Ease, Inc.), the optimization process was facilitated with eleven experimental runs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Utilizing",
"Design-Expert",
"(",
"Version",
"11",
",",
"State-Ease",
",",
"Inc.",
")",
",",
"the",
"optimization",
"process",
"was",
"facilitated",
"with",
"eleven",
"experimental",
"runs",
"."
]
}
] |
PMC7334607 | Bottom, a plot of the dose-response curve for Replicate 5 and all control replicates in response to dactinomycin at the VDC4 time point. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Bottom",
",",
"a",
"plot",
"of",
"the",
"dose-response",
"curve",
"for",
"Replicate",
"5",
"and",
"all",
"control",
"replicates",
"in",
"response",
"to",
"dactinomycin",
"at",
"the",
"VDC4",
"time",
"point",
"."
]
}
] |
PMC10158546 | We also noticed that slower migrating species of PrP were lost upon differentiation in both ReN 129 M and WT cells, whereas faster migrating species became predominant (Figure 3b). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"I-CellLine",
"I-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"also",
"noticed",
"that",
"slower",
"migrating",
"species",
"of",
"PrP",
"were",
"lost",
"upon",
"differentiation",
"in",
"both",
"ReN",
"129",
"M",
"and",
"WT",
"cells",
",",
"whereas",
"faster",
"migrating",
"species",
"became",
"predominant",
"(",
"Figure",
"3b",
")",
"."
]
}
] |
PMC11774251 | In addition, the expression of inflammation-related genes, including IL-1β, S100A7, CXCL2, CXCL5, CXCL8, and CCL3, was significantly upregulated in TNF-α-induced HaCaT cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"the",
"expression",
"of",
"inflammation-related",
"genes",
",",
"including",
"IL-1β",
",",
"S100A7",
",",
"CXCL2",
",",
"CXCL5",
",",
"CXCL8",
",",
"and",
"CCL3",
",",
"was",
"significantly",
"upregulated",
"in",
"TNF-α-induced",
"HaCaT",
"cells",
"."
]
}
] |
PMC11420784 | The interaction between PI3P and target proteins is mediated by a conserved zinc-finger domain, FYVE . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"interaction",
"between",
"PI3P",
"and",
"target",
"proteins",
"is",
"mediated",
"by",
"a",
"conserved",
"zinc-finger",
"domain",
",",
"FYVE",
"."
]
}
] |
PMC11194678 | We further showed that STAU1-overexpressed cells treated with bafilomycin A1 (BafA1, an inhibitor of autophagosome–lysosome fusion) did not further increase LC3-II and p62 levels (Fig. S3 D), demonstrating that STAU1 was indeed involved in inhibiting autophagosome–lysosome fusion. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"further",
"showed",
"that",
"STAU1-overexpressed",
"cells",
"treated",
"with",
"bafilomycin",
"A1",
"(",
"BafA1",
",",
"an",
"inhibitor",
"of",
"autophagosome",
"–",
"lysosome",
"fusion",
")",
"did",
"not",
"further",
"increase",
"LC3-II",
"and",
"p62",
"levels",
"(",
"Fig.",
"S3",
"D",
")",
",",
"demonstrating",
"that",
"STAU1",
"was",
"indeed",
"involved",
"in",
"inhibiting",
"autophagosome",
"–",
"lysosome",
"fusion",
"."
]
}
] |
PMC11252553 | The findings indicate that increasing the concentration of Taurine beyond 100 μM can lead to decreasing lymphocyte viability of the experimental group at both 48 and 72 hours. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"findings",
"indicate",
"that",
"increasing",
"the",
"concentration",
"of",
"Taurine",
"beyond",
"100",
"μM",
"can",
"lead",
"to",
"decreasing",
"lymphocyte",
"viability",
"of",
"the",
"experimental",
"group",
"at",
"both",
"48",
"and",
"72",
"hours",
"."
]
}
] |
PMC10587429 | Gate viable cells and exclude cell debris. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Gate",
"viable",
"cells",
"and",
"exclude",
"cell",
"debris",
"."
]
}
] |
PMC10854447 | C18H13N5O3: C, 62.24; H, 3.77; N, 20.16. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"C18H13N5O3",
":",
"C",
",",
"62.24",
";",
"H",
",",
"3.77",
";",
"N",
",",
"20.16",
"."
]
}
] |
PMC11322866 | In summary, increased phosphorylation of ERK1/2 is required for cellular senescence induced by the inhibition of EZH2 in MM cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"summary",
",",
"increased",
"phosphorylation",
"of",
"ERK1/2",
"is",
"required",
"for",
"cellular",
"senescence",
"induced",
"by",
"the",
"inhibition",
"of",
"EZH2",
"in",
"MM",
"cells",
"."
]
}
] |
PMC11585994 | Each sample was prepared in triplicate (n = 3), with three measurements conducted for each sample using the Zetasizer Nano ZS in Jinan University Analytical and Testing Center. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Each",
"sample",
"was",
"prepared",
"in",
"triplicate",
"(",
"n",
"=",
"3",
")",
",",
"with",
"three",
"measurements",
"conducted",
"for",
"each",
"sample",
"using",
"the",
"Zetasizer",
"Nano",
"ZS",
"in",
"Jinan",
"University",
"Analytical",
"and",
"Testing",
"Center",
"."
]
}
] |
PMC11703896 | The 3D images show rapamycin’s positioning within the receptor binding pockets, highlighting key hydrophobic and hydrogen bond interactions. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"3D",
"images",
"show",
"rapamycin",
"’s",
"positioning",
"within",
"the",
"receptor",
"binding",
"pockets",
",",
"highlighting",
"key",
"hydrophobic",
"and",
"hydrogen",
"bond",
"interactions",
"."
]
}
] |
PMC11534377 | Subsequently, the microarray slides were scanned using an Agilent G2565CA microarray scanner. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Subsequently",
",",
"the",
"microarray",
"slides",
"were",
"scanned",
"using",
"an",
"Agilent",
"G2565CA",
"microarray",
"scanner",
"."
]
}
] |
PMC6742971 | We observed that the high avidity clone 212 produced higher numbers of spots in comparison with the low avidity clone. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"observed",
"that",
"the",
"high",
"avidity",
"clone",
"212",
"produced",
"higher",
"numbers",
"of",
"spots",
"in",
"comparison",
"with",
"the",
"low",
"avidity",
"clone",
"."
]
}
] |
PMC11512230 | In addition, virus particles are relatively easy and rapid to grow in plants, and their production is inexpensive and scalable . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"virus",
"particles",
"are",
"relatively",
"easy",
"and",
"rapid",
"to",
"grow",
"in",
"plants",
",",
"and",
"their",
"production",
"is",
"inexpensive",
"and",
"scalable",
"."
]
}
] |
PMC11228511 | A description is provided in SI Appendix. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"description",
"is",
"provided",
"in",
"SI",
"Appendix",
"."
]
}
] |
PMC9429973 | Results: Using an unsupervised method, 4 patient clusters were identified that represented 10%, 57%, 15%, and 18%, respectively, of the total 164 patients. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Results",
":",
"Using",
"an",
"unsupervised",
"method",
",",
"4",
"patient",
"clusters",
"were",
"identified",
"that",
"represented",
"10",
"%",
",",
"57",
"%",
",",
"15",
"%",
",",
"and",
"18",
"%",
",",
"respectively",
",",
"of",
"the",
"total",
"164",
"patients",
"."
]
}
] |
PMC11655536 | Interestingly, the lysosomes in the HA-treated MM cells were swelling (Fig. 3H). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Interestingly",
",",
"the",
"lysosomes",
"in",
"the",
"HA-treated",
"MM",
"cells",
"were",
"swelling",
"(",
"Fig.",
"3H",
")",
"."
]
}
] |
PMC10940855 | It also contains various growth factors (TGFβ, FGF) and proteolytic enzymes (plasminogen, tPA, MMPs). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"also",
"contains",
"various",
"growth",
"factors",
"(",
"TGFβ",
",",
"FGF",
")",
"and",
"proteolytic",
"enzymes",
"(",
"plasminogen",
",",
"tPA",
",",
"MMPs",
")",
"."
]
}
] |
PMC11012012 | SLAMF7/CD319, along with SLAMF1/CD150, was shown to affect the degranulation capacity of primary NK cells from CLL patients and have an antagonistic effect on the BCR pathway via recruitment of prohibitin-2 (PHB2) . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"SLAMF7/CD319",
",",
"along",
"with",
"SLAMF1/CD150",
",",
"was",
"shown",
"to",
"affect",
"the",
"degranulation",
"capacity",
"of",
"primary",
"NK",
"cells",
"from",
"CLL",
"patients",
"and",
"have",
"an",
"antagonistic",
"effect",
"on",
"the",
"BCR",
"pathway",
"via",
"recruitment",
"of",
"prohibitin-2",
"(",
"PHB2",
")",
"."
]
}
] |
PMC11798926 | Cells were live labeled on ice with appropriate primary and secondary antibodies to recognize an extracellular epitope tag, then fixed and stained for total expression of the same molecule. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cells",
"were",
"live",
"labeled",
"on",
"ice",
"with",
"appropriate",
"primary",
"and",
"secondary",
"antibodies",
"to",
"recognize",
"an",
"extracellular",
"epitope",
"tag",
",",
"then",
"fixed",
"and",
"stained",
"for",
"total",
"expression",
"of",
"the",
"same",
"molecule",
"."
]
}
] |
PMC11366496 | The outcomes indicated that only p‐JAK2, p‐STAT3, and c‐Myc were downregulated by RNF122 knocking down while promoted by RNF122 overexpression (Figure 4A,B). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"outcomes",
"indicated",
"that",
"only",
"p‐JAK2",
",",
"p‐STAT3",
",",
"and",
"c‐Myc",
"were",
"downregulated",
"by",
"RNF122",
"knocking",
"down",
"while",
"promoted",
"by",
"RNF122",
"overexpression",
"(",
"Figure",
"4A",
",",
"B",
")",
"."
]
}
] |
PMC11122631 | Thus, the DP4+ probability analysis was selected to determine the configuration of C-4. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Thus",
",",
"the",
"DP4",
"+",
"probability",
"analysis",
"was",
"selected",
"to",
"determine",
"the",
"configuration",
"of",
"C-4",
"."
]
}
] |
PMC10907726 | All other data relevant to this study are included within this publication. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"other",
"data",
"relevant",
"to",
"this",
"study",
"are",
"included",
"within",
"this",
"publication",
"."
]
}
] |
PMC9429973 | However, resistance caused by BTK mutations, which can abrogate BTKi binding capacity or BTK scaffold function, or cause kinase hyper activation, may limit therapeutic options in subsequent lines of therapy. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"resistance",
"caused",
"by",
"BTK",
"mutations",
",",
"which",
"can",
"abrogate",
"BTKi",
"binding",
"capacity",
"or",
"BTK",
"scaffold",
"function",
",",
"or",
"cause",
"kinase",
"hyper",
"activation",
",",
"may",
"limit",
"therapeutic",
"options",
"in",
"subsequent",
"lines",
"of",
"therapy",
"."
]
}
] |
PMC11577421 | In contrast, ABNPs lacking attractive interactions with surface GAGs may be particularly suited for selective drug delivery to cells with a damaged glycocalyx, which is typical of various pathological conditions, such as atherosclerosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"contrast",
",",
"ABNPs",
"lacking",
"attractive",
"interactions",
"with",
"surface",
"GAGs",
"may",
"be",
"particularly",
"suited",
"for",
"selective",
"drug",
"delivery",
"to",
"cells",
"with",
"a",
"damaged",
"glycocalyx",
",",
"which",
"is",
"typical",
"of",
"various",
"pathological",
"conditions",
",",
"such",
"as",
"atherosclerosis",
"."
]
}
] |
PMC11047729 | Perfluorooctanesulfonate (PFOS) is a global pollutant that can cause toxic effects on various cells, including blood cells, which can result in leukemia. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Perfluorooctanesulfonate",
"(",
"PFOS",
")",
"is",
"a",
"global",
"pollutant",
"that",
"can",
"cause",
"toxic",
"effects",
"on",
"various",
"cells",
",",
"including",
"blood",
"cells",
",",
"which",
"can",
"result",
"in",
"leukemia",
"."
]
}
] |
PMC11535726 | The aligned Fasta file was converted into a Nexus format for subsequent Bayesian analysis using AliView version 1.27 (Daniel et al. 2010). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"aligned",
"Fasta",
"file",
"was",
"converted",
"into",
"a",
"Nexus",
"format",
"for",
"subsequent",
"Bayesian",
"analysis",
"using",
"AliView",
"version",
"1.27",
"(",
"Daniel",
"et",
"al.",
"2010",
")",
"."
]
}
] |
PMC9429973 | Aims: Although hip arthroplasty-derived BM serves as an available resource for non-malignant hematopoietic cell research, the BMAT component of this BM and its’ impact on hematopoietic progenitors is not yet revealed. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Aims",
":",
"Although",
"hip",
"arthroplasty-derived",
"BM",
"serves",
"as",
"an",
"available",
"resource",
"for",
"non-malignant",
"hematopoietic",
"cell",
"research",
",",
"the",
"BMAT",
"component",
"of",
"this",
"BM",
"and",
"its",
"’",
"impact",
"on",
"hematopoietic",
"progenitors",
"is",
"not",
"yet",
"revealed",
"."
]
}
] |
PMC9429973 | Pre-treatment presence of somatic mutations were associated with development of grade 3/4 hematological toxicity. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Pre-treatment",
"presence",
"of",
"somatic",
"mutations",
"were",
"associated",
"with",
"development",
"of",
"grade",
"3/4",
"hematological",
"toxicity",
"."
]
}
] |
PMC11518994 | This report sheds light on diverse mechanisms contributing to leukemogenesis in the context of PAX5 germline mutation. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"report",
"sheds",
"light",
"on",
"diverse",
"mechanisms",
"contributing",
"to",
"leukemogenesis",
"in",
"the",
"context",
"of",
"PAX5",
"germline",
"mutation",
"."
]
}
] |
PMC9581083 | Since its emergence in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) has had devastating effects worldwide, with more than 362 million confirmed cases and 5.62 million deaths globally by early February 2022 (Wu et al., 2020a). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Since",
"its",
"emergence",
"in",
"December",
"2019",
",",
"severe",
"acute",
"respiratory",
"syndrome",
"coronavirus",
"2",
"(",
"SARS-CoV-2",
",",
"COVID-19",
")",
"has",
"had",
"devastating",
"effects",
"worldwide",
",",
"with",
"more",
"than",
"362",
"million",
"confirmed",
"cases",
"and",
"5.62",
"million",
"deaths",
"globally",
"by",
"early",
"February",
"2022",
"(",
"Wu",
"et",
"al.",
",",
"2020a",
")",
"."
]
}
] |
PMC11441402 | Each of the existing methods have limitations. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Each",
"of",
"the",
"existing",
"methods",
"have",
"limitations",
"."
]
}
] |
PMC11422150 | The results and previous publications utilizing kinematic analyses provide strong evidence supporting the use of kinematic analyses in both rodent experiments and clinical studies (DiGiovanna et al., 2016; Kawai et al., 2015; Miri et al., 2017; Ueno and Yamashita, 2011; Ueno et al., 2018), which was very effective in detecting the subtle discrepancy. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"results",
"and",
"previous",
"publications",
"utilizing",
"kinematic",
"analyses",
"provide",
"strong",
"evidence",
"supporting",
"the",
"use",
"of",
"kinematic",
"analyses",
"in",
"both",
"rodent",
"experiments",
"and",
"clinical",
"studies",
"(",
"DiGiovanna",
"et",
"al.",
",",
"2016",
";",
"Kawai",
"et",
"al.",
",",
"2015",
";",
"Miri",
"et",
"al.",
",",
"2017",
";",
"Ueno",
"and",
"Yamashita",
",",
"2011",
";",
"Ueno",
"et",
"al.",
",",
"2018",
")",
",",
"which",
"was",
"very",
"effective",
"in",
"detecting",
"the",
"subtle",
"discrepancy",
"."
]
}
] |
PMC9545474 | All reactions were performed under standard Schlenk conditions unless otherwise stated. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"reactions",
"were",
"performed",
"under",
"standard",
"Schlenk",
"conditions",
"unless",
"otherwise",
"stated",
"."
]
}
] |
PMC11127909 | An ATP luminescence 1-step assay kit (PerkinElmer; #6016731) was used to measure the ATP concentration. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"An",
"ATP",
"luminescence",
"1-step",
"assay",
"kit",
"(",
"PerkinElmer",
";",
"#",
"6016731",
")",
"was",
"used",
"to",
"measure",
"the",
"ATP",
"concentration",
"."
]
}
] |
PMC11543853 | Previous studies demonstrated that enteroviruses utilize clathrin-dependent, caveolin-dependent, and other types of endocytosis for cell entry. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Previous",
"studies",
"demonstrated",
"that",
"enteroviruses",
"utilize",
"clathrin-dependent",
",",
"caveolin-dependent",
",",
"and",
"other",
"types",
"of",
"endocytosis",
"for",
"cell",
"entry",
"."
]
}
] |
PMC11449273 | Cells from 100 mm cultures of H1299 and H1299-p53-(WT, R175H, R273H) transfectants were extracted in 750 μL RIPA lysis buffer for 20 min on a rocker-rotator at 4°C. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cells",
"from",
"100",
"mm",
"cultures",
"of",
"H1299",
"and",
"H1299-p53-(WT",
",",
"R175H",
",",
"R273H",
")",
"transfectants",
"were",
"extracted",
"in",
"750",
"μL",
"RIPA",
"lysis",
"buffer",
"for",
"20",
"min",
"on",
"a",
"rocker-rotator",
"at",
"4",
"°",
"C",
"."
]
}
] |
PMC11185260 | Induction of apoptosis was monitored via Annexin V/PI staining in A-204. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O"
],
"tokens": [
"Induction",
"of",
"apoptosis",
"was",
"monitored",
"via",
"Annexin",
"V/PI",
"staining",
"in",
"A-204",
"."
]
}
] |
PMC11026382 | DHFR kcat and Km were determined under Michaelis-Menten conditions with saturating concentrations of NADPH as in prior work. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"DHFR",
"kcat",
"and",
"Km",
"were",
"determined",
"under",
"Michaelis-Menten",
"conditions",
"with",
"saturating",
"concentrations",
"of",
"NADPH",
"as",
"in",
"prior",
"work",
"."
]
}
] |
PMC11742431 | It could be found that the proteins containing Nb4A cleaved by Furin protease were gradually enriched intracellularly with increasing time, but they could not enter the nucleus (Figure 6A,E). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"could",
"be",
"found",
"that",
"the",
"proteins",
"containing",
"Nb4A",
"cleaved",
"by",
"Furin",
"protease",
"were",
"gradually",
"enriched",
"intracellularly",
"with",
"increasing",
"time",
",",
"but",
"they",
"could",
"not",
"enter",
"the",
"nucleus",
"(",
"Figure",
"6A",
",",
"E",
")",
"."
]
}
] |
PMC11696576 | The organic solvent was evaporated under reduced pressure and the residue was purified by column chromatography [EtOAc-petroleum ether (bp 40–60 °C), 1:9]. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"organic",
"solvent",
"was",
"evaporated",
"under",
"reduced",
"pressure",
"and",
"the",
"residue",
"was",
"purified",
"by",
"column",
"chromatography",
"[",
"EtOAc-petroleum",
"ether",
"(",
"bp",
"40–60",
"°",
"C",
")",
",",
"1:9",
"]",
"."
]
}
] |
PMC10955424 | Overexpression of c-MET was reported in 7–27 % of OC patients. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Overexpression",
"of",
"c-MET",
"was",
"reported",
"in",
"7–27",
"%",
"of",
"OC",
"patients",
"."
]
}
] |
PMC6627640 | The TCGA and other exome sequencing studies have not identified any recurrent mutations or genomic alterations in PRC1 and PRC2 genes in TGCTs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"TCGA",
"and",
"other",
"exome",
"sequencing",
"studies",
"have",
"not",
"identified",
"any",
"recurrent",
"mutations",
"or",
"genomic",
"alterations",
"in",
"PRC1",
"and",
"PRC2",
"genes",
"in",
"TGCTs",
"."
]
}
] |
PMC10998613 | We also repeated the measurements in HCC4006 cells, a human lung cancer line in which the endogenous expression of CXCR4 and β2AR is low. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"also",
"repeated",
"the",
"measurements",
"in",
"HCC4006",
"cells",
",",
"a",
"human",
"lung",
"cancer",
"line",
"in",
"which",
"the",
"endogenous",
"expression",
"of",
"CXCR4",
"and",
"β2AR",
"is",
"low",
"."
]
}
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.